Proxy Results Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 10, 2024, Sunshine Biopharma Inc. (the "Company") held its annual meeting of stockholders. At the meeting, (i) Dr. Steve N. Slilaty, Dr. Abderrazzak Merzouki, Dr. Rabi Kiderchah, Mr. David Natan, and Dr. Andrew Keller were each elected as directors of the Company to serve until the next annual meeting of stockholders or until their successors have been elected and qualified, and (ii) stockholders ratified the board of directors' appointment of Bush & Associates CPA LLC as the Company's independent registered public accounting firm for 2024.

The vote on these matters was as follows:

1. Election of Directors:
		FOR		WITHHELD		BROKER NON-VOTE
Dr. Steve N. Slilaty		130,067,932		48,554		0
Dr. Abderrazzak Merzouki		130,080,510		35,976		0
Dr. Rabi Kiderchah		130,076,086		40,400		0
Mr. David Natan		130,070,417		46,069		0
Dr. Andrew Keller		130,075,596		40,890		0

2. Ratification of the board of directors' appointment of Bush & Associates CPA LLC as the Company's independent registered public accounting firm for 2024.

FOR		AGAINST		ABSTAIN
130,089,305		15,456		11,725

Public link

Please use the above public link if you want to share this noodl on another website.